Trial Profile
Inhaled corticosteroids for treating active lung disease in survivors of preterm birth
Status:
Suspended
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Fluticasone propionate (Primary)
- Indications Lung disorders
- Focus Therapeutic Use
- Acronyms PICSI
- 23 Apr 2020 Status changed from recruiting to suspended.
- 13 May 2019 Planned number of patients changed from 200 to 250.
- 13 May 2019 Status changed from not yet recruiting to recruiting.